Literature DB >> 15295339

Pregnancy outcomes after treatment for fibromyomata: uterine artery embolization versus laparoscopic myomectomy.

Jay Goldberg1, Leonardo Pereira, Vincenzo Berghella, James Diamond, Emile Daraï, Piero Seinera, Renato Seracchioli.   

Abstract

OBJECTIVE: The objective of this study was to compare pregnancy outcomes in women with fibromyomata who were treated with uterine artery embolization to the outcomes in women who were treated with laparoscopic myomectomy. STUDY
DESIGN: We compiled data from 53 pregnancies after uterine artery embolization and 139 pregnancies after laparoscopic myomectomy. We calculated and compared rates for spontaneous abortion, postpartum hemorrhage, preterm delivery, cesarean delivery, small for gestational age, and malpresentation.
RESULTS: Pregnancies after uterine artery embolization had higher rates of preterm delivery (odds ratio, 6.2; 95% CI, 1.4, 27.7) and malpresentation (odds ratio, 4.3; 95% CI, 1.0, 20.5) than did pregnancies after laparoscopic myomectomy. The risks of postpartum hemorrhage (odds ratio, 6.3; 95% CI, 0.6, 71.8) and spontaneous abortion (odds ratio, 1.7; 95% CI, 0.8, 3.9) after uterine artery embolization were similarly higher than the risks after laparoscopic myomectomy; however, these differences were not statistically significant.
CONCLUSION: Pregnancies in women with fibromyomata who were treated by uterine artery embolization, compared with pregnancies after laparoscopic myomectomy, were at increased risk for preterm delivery and malpresentation.

Entities:  

Mesh:

Year:  2004        PMID: 15295339     DOI: 10.1016/j.ajog.2004.01.046

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  18 in total

1.  Contemporary management of fibroids in pregnancy.

Authors:  Hee Joong Lee; Errol R Norwitz; Julia Shaw
Journal:  Rev Obstet Gynecol       Date:  2010

Review 2.  The impact of uterine leiomyomas on reproductive outcomes.

Authors:  H Cook; M Ezzati; J H Segars; K McCarthy
Journal:  Minerva Ginecol       Date:  2010-06

3.  Uterine artery embolization versus abdominal myomectomy: a long-term clinical outcome comparison.

Authors:  Anand Narayan; Adrea S Lee; George P Kuo; Neil Powe; Hyun S Kim
Journal:  J Vasc Interv Radiol       Date:  2010-05-31       Impact factor: 3.464

Review 4.  Pregnancy success and outcomes after uterine fibroid embolization: updated review of published literature.

Authors:  Parker E Ludwig; Trevor J Huff; Meaghan M Shanahan; Joseph M Stavas
Journal:  Br J Radiol       Date:  2019-10-08       Impact factor: 3.039

5.  Prediction of operation time for laparoscopic myomectomy by ultrasound measurements.

Authors:  Wen-Chiung Hsu; Jing-Shiang Hwang; Wen-Chun Chang; Su-Cheng Huang; Bor-Ching Sheu; Pao-Ling Torng
Journal:  Surg Endosc       Date:  2007-02-09       Impact factor: 4.584

Review 6.  Uterine fibroid embolization: CME update for family physicians.

Authors:  Antony Raikhlin; Mark Otto Baerlocher; Murray R Asch
Journal:  Can Fam Physician       Date:  2007-02       Impact factor: 3.275

7.  Uterine Fibroid Embolisation - Potential Impact on Fertility and Pregnancy Outcome.

Authors:  M David; T Kröncke
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-03       Impact factor: 2.915

Review 8.  Management of uterine fibroids in the patient pursuing assisted reproductive technologies.

Authors:  Mohammad Ezzati; John M Norian; James H Segars
Journal:  Womens Health (Lond)       Date:  2009-07

Review 9.  Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances.

Authors:  Gary Levy; Micah J Hill; Stephanie Beall; Shvetha M Zarek; James H Segars; William H Catherino
Journal:  J Assist Reprod Genet       Date:  2012-05-15       Impact factor: 3.412

10.  Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy.

Authors:  Michal Mara; Jana Maskova; Zuzana Fucikova; David Kuzel; Tomas Belsan; Ondrej Sosna
Journal:  Cardiovasc Intervent Radiol       Date:  2007-10-18       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.